Similar articles for PMID: 29635081

Year	Number of Results
1956	1
1957	1
1961	1
1963	1
1964	1
1989	1
1991	3
1993	2
1994	3
1995	2
1997	1
1998	3
1999	1
2002	1
2003	5
2005	1
2006	2
2007	3
2008	5
2009	6
2010	7
2011	4
2012	14
2013	18
2014	17
2015	21
2016	29
2017	35
2018	48
2019	66
2020	46
2021	61
2022	42
2023	17
2024	1

1

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.

Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, Scheibenbogen C; European Network on ME/CFS (EUROMENE). Sotzny F, et al. Autoimmun Rev. 2018 Jun;17(6):601-609. doi: 10.1016/j.autrev.2018.01.009. Epub 2018 Apr 7. Autoimmun Rev. 2018. PMID: 29635081 Free article. Review.

2

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.

Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik S. Eaton N, et al. BMC Pharmacol Toxicol. 2018 Mar 27;19(1):12. doi: 10.1186/s40360-018-0203-8. BMC Pharmacol Toxicol. 2018. PMID: 29587879 Free PMC article.

3

Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Mensah F, Bansal A, Berkovitz S, Sharma A, Reddy V, Leandro MJ, Cambridge G. Mensah F, et al. Clin Exp Immunol. 2016 May;184(2):237-47. doi: 10.1111/cei.12749. Epub 2016 Feb 22. Clin Exp Immunol. 2016. PMID: 26646713 Free PMC article.

4

A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.

Wirth K, Scheibenbogen C. Wirth K, et al. Autoimmun Rev. 2020 Jun;19(6):102527. doi: 10.1016/j.autrev.2020.102527. Epub 2020 Apr 1. Autoimmun Rev. 2020. PMID: 32247028 Free article. Review.

5

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø. Lunde S, et al. PLoS One. 2016 Aug 18;11(8):e0161226. doi: 10.1371/journal.pone.0161226. eCollection 2016. PLoS One. 2016. PMID: 27536947 Free PMC article. Clinical Trial.

6

[Immunopathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)].

Yamamura T, Ono H, Sato W. Yamamura T, et al. Brain Nerve. 2018 Jan;70(1):35-40. doi: 10.11477/mf.1416200947. Brain Nerve. 2018. PMID: 29348373 Japanese.

7

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.

Maes M, Mihaylova I, Kubera M, Leunis JC, Twisk FN, Geffard M. Maes M, et al. Metab Brain Dis. 2012 Dec;27(4):415-23. doi: 10.1007/s11011-012-9316-8. Epub 2012 May 22. Metab Brain Dis. 2012. PMID: 22614823

8

Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Szklarski M, Freitag H, Lorenz S, Becker SC, Sotzny F, Bauer S, Hartwig J, Heidecke H, Wittke K, Kedor C, Hanitsch LG, Grabowski P, Sepúlveda N, Scheibenbogen C. Szklarski M, et al. Front Immunol. 2021 Apr 6;12:644548. doi: 10.3389/fimmu.2021.644548. eCollection 2021. Front Immunol. 2021. PMID: 33889154 Free PMC article.

9

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S. Hardcastle SL, et al. BMC Immunol. 2015 Jun 2;16:35. doi: 10.1186/s12865-015-0101-4. BMC Immunol. 2015. PMID: 26032326 Free PMC article.

10

Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.

Maes M, Leunis JC. Maes M, et al. Neuro Endocrinol Lett. 2014;35(7):577-85. Neuro Endocrinol Lett. 2014. PMID: 25617880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

428 results

Results by year